Life Science

add news feed

post a story

Properties, sources and uses of the element xenon.
Properties, sources and uses of the element xenon.
about 6 hours ago
Aquaculture industry may be vulnerable to disease outbreaks.
Aquaculture industry may be vulnerable to disease outbreaks.
about 6 hours ago
Kids may use little sounds and air puffs as stand-ins for grammatical words.
Kids may use little sounds and air puffs as stand-ins for grammatical words.
about 7 hours ago
A survey of children with food allergies showed that a third of them reported being bullied with threatening behavior.
A survey of children with food allergies showed that a third of them reported being bullied with threatening behavior.
about 7 hours ago
Some futurists predict humans will be able to upload their consciousness to computers in the near future.
Some futurists predict humans will be able to upload their consciousness to computers in the near future.
about 7 hours ago
A letter to the Editor.
A letter to the Editor.
about 7 hours ago
A letter to the Editor.
A letter to the Editor.
about 7 hours ago
A letter to the Editor.
A letter to the Editor.
about 7 hours ago
A team of researchers has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways. Although isoniazid and rifampin, two front-line TB drugs, came into use in 1952 an...
A team of researchers has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways. Although isoniazid and rifampin, two front-line TB drugs, came into use in 1952 and 1967 respectively, new TB infections still occur at the rate of roughly one per second. At any moment about a third of the existing human population is infected. Though it is mostly winactive, latent TB, active TB still kills over one million people each year, with Russia, Africa, China and Southeast Asia especially hard hit. read more
about 8 hours ago
Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks.
Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks.
about 8 hours ago